GH

Guardant Health (GH)

Guardant Health Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:GH

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/17	07:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2025/01/17	07:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2025/01/16	22:05	Business Wire	Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development	NASDAQ:GH	Guardant Health Inc
2025/01/14	06:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GH	Guardant Health Inc
2025/01/13	21:00	Business Wire	Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results	NASDAQ:GH	Guardant Health Inc
2025/01/07	22:03	Business Wire	Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection	NASDAQ:GH	Guardant Health Inc
2025/01/07	08:25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2025/01/04	08:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2025/01/04	08:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2025/01/04	07:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2025/01/04	07:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2025/01/04	07:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2025/01/04	07:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2025/01/04	07:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2025/01/03	06:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2025/01/03	06:05	Business Wire	Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:GH	Guardant Health Inc
2024/12/20	22:05	Business Wire	Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care	NASDAQ:GH	Guardant Health Inc
2024/12/20	08:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/12/19	20:00	Business Wire	COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics	NASDAQ:GH	Guardant Health Inc
2024/12/19	06:38	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GH	Guardant Health Inc
2024/12/18	22:05	Business Wire	Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer	NASDAQ:GH	Guardant Health Inc
2024/12/17	08:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/12/17	08:25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/12/17	08:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/12/17	08:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/12/17	08:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/12/14	06:30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GH	Guardant Health Inc
2024/12/09	22:05	Business Wire	Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium	NASDAQ:GH	Guardant Health Inc
2024/12/06	08:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/12/04	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc